Jain A, Rutter N
Department of Neonatal Medicine, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.
Arch Dis Child Fetal Neonatal Ed. 2000 Nov;83(3):F207-10. doi: 10.1136/fn.83.3.f207.
Topical amethocaine provides effective pain relief during venepuncture in children, and has been shown to have a local anaesthetic action in the newborn.
To investigate the effect of topical amethocaine on the pain of venepuncture in the newborn.
Randomised double blind placebo controlled trial.
Forty newborn infants, gestation 27-41 weeks (median 33), age 2-17 days (median 7), undergoing routine venepuncture.
A 1.5 g portion of 4% (w/w) amethocaine gel (Ametop; Smith and Nephew, Hull, UK) or placebo was applied to the skin under occlusion for one hour, then wiped away. Venepuncture was performed five minutes later. Facial reaction and cry were recorded on videotape. Pain was assessed using a validated adaptation of the neonatal facial coding system. Five features were scored at one second intervals for five seconds before and after venepuncture. No or minimal pain was defined as a cumulative score of below 10 (out of 25) in the five seconds after needle insertion. Each author scored the tapes independently.
There was close agreement on scoring of the tapes. One infant was excluded because of restlessness before the venepuncture. Of 19 amethocaine treated infants, 16 (84%) showed little or no pain compared with six of 20 (30%) in the placebo group (p = 0.001). The median cumulative neonatal facial coding system score over five seconds after needle insertion was 3 compared with 16 in the placebo group (p = 0.001). Of the 19 amethocaine treated infants, 15 (79%) did not cry compared with five of 20 (25%) placebo treated infants (p = 0.001). No local reaction to amethocaine was seen.
Topical amethocaine provides effective pain relief during venepuncture in the newborn.
局部应用丁卡因可有效缓解儿童静脉穿刺时的疼痛,且已证实其对新生儿有局部麻醉作用。
研究局部应用丁卡因对新生儿静脉穿刺疼痛的影响。
随机双盲安慰剂对照试验。
40例孕周27 - 41周(中位数33周)、年龄2 - 17天(中位数7天)的新生儿,接受常规静脉穿刺。
将1.5克4%(w/w)丁卡因凝胶(Ametop;英国赫尔的施乐辉公司)或安慰剂在封闭状态下涂抹于皮肤1小时,然后擦去。5分钟后进行静脉穿刺。面部反应和哭声被录像记录。使用经过验证的新生儿面部编码系统改编版评估疼痛。在静脉穿刺前后5秒内,每隔1秒对5个特征进行评分。无疼痛或轻微疼痛定义为穿刺后5秒内累积评分低于10分(满分25分)。每位作者独立对录像带进行评分。
录像带评分结果高度一致。1例婴儿因穿刺前躁动被排除。19例接受丁卡因治疗的婴儿中,16例(84%)显示几乎没有疼痛,而安慰剂组20例中有6例(30%)(p = 0.001)。穿刺后5秒内新生儿面部编码系统的中位数累积评分在丁卡因组为3分,而安慰剂组为16分(p = 0.001)。19例接受丁卡因治疗的婴儿中,15例(79%)未哭,而安慰剂组20例中有5例(25%)(p = 0.001)。未观察到对丁卡因的局部反应。
局部应用丁卡因可有效缓解新生儿静脉穿刺时的疼痛。